









Markets
/
Stocks
/
nasdaq-mdcxw
/

Medicus Pharma Ltd

MDCXW

View Detailed Chart

0.930USD

+0.080+9.41%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Medicus Pharma Ltd

0.930

+0.080+9.41%

Overview Company Financials

Financials

Intraday

30m

Today

+9.41%

5 Days

-9.70%

1 Month

-7.00%

6 Months

-15.45%

Year to Date

+42.86%

1 Year

0.00%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(8)

Neutral(0)

Buy(2)

Indicators

Sell(4)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.146

Sell

RSI(14)

23.211

Sell

STOCH(KDJ)(9,3,3)

10.006

Sell

ATR(14)

0.200

Low Volatility

CCI(14)

-389.213

Oversold

Williams %R

100.000

Oversold

TRIX(12,20)

-0.478

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

0.712

Buy

MA10

0.873

Buy

MA20

0.954

Sell

MA50

1.022

Sell

MA100

0.949

Sell

MA200

0.933

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The Company investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The Company is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.

Ticker SymbolMDCXW

CompanyMedicus Pharma Ltd

CEODr. Raza Bokhari, M.D.

Websitehttps://medicuspharma.com/